COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,286 Articles (22,759 medRxiv, 8,527 bioRxiv)

Most recent first Previous |  Page 862: Articles 8611-8620  | Next

SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications
Schloer, A., Hirschberg, S., Ben Amor, G., Meister, T. L., Arora, P., Pöhlmann, S., Hoffmann, M., Pfaender, S., Kamal Eddin, O., Kamhieh-Milz, J., Hanack, K.
10.1101/2022.03.24.485614 — Posted: 2022-03-24
Differences in neuroinflammation in the olfactory bulb between D614G, Delta and Omicron BA.1 SARS-CoV-2 variants in the hamster model
Bauer, L., Rissmann, M., Benavides, F., Leijten, L., Begeman, L., Veldhuis Kroeze, E., van Run, P., Koopmans, M. P. G., Rockx, B., van Riel, D.
10.1101/2022.03.24.485596 — Posted: 2022-03-24
Influenza infection in ferrets with SARS-CoV-2 infection history
de Melo, C. V. B., Peters, F., van Dijken, H., Lenz, S., van de Ven, K., Wijsman, L., Gommersbach, A., Schouten, T., van Kasteren, P. B., van den Brand, J. M. A., de Jonge, J.
10.1101/2022.03.22.485425 — Posted: 2022-03-24
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice
Gonzalez-Dominguez, I., Martinez, J. L., Slamanig, S., Lemus, N., Liu, Y., Lai, T. Y., Carreno, J. M., Singh, G., Singh, G., Schotsaert, M., Mena, I., McCroskery, S., Coughlan, L., Krammer, F., Garcia-Sastre, A., Palese, P., Sun, W.
10.1101/2022.03.21.485247 — Posted: 2022-03-24
Clinical validation and the evaluation of a colorimetric SARS-CoV-2 RT-LAMP assay identify its robustness against RT-PCR
Erdem, M., Andac-Ozketen, A., Ozketen, A. C., Karahan, G., Tozluyurt, A., Palaz, F., Alp, A., Unal, S.
10.1101/2022.03.21.22271747 — Posted: 2022-03-23
Undiagnosed COVID-19 in households with a child with mitochondrial disease
Gordon-Lipkin, E. M., Marcum, C., Kruk, S., Thompson, E., Kelly, S. E. M., Kalish, H., Sadtler, K., McGuire, P.
10.1101/2022.03.21.22272358 — Posted: 2022-03-23
Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records
Horne, E. M., Hulme, W. J., Keogh, R. H., Palmer, T. M., Williamson, E. J., Parker, E. P., Green, A., Walker, V., Walker, A. J., Curtis, H., Fisher, L., MacKenna, B., Croker, R., Hopcroft, L., Park, R. Y., Massey, J., Morely, J., Mehrkar, A., Bacon, S., Evans, D., Inglesby, P., Morton, C. E., Hickman, G., Davy, S., Ward, T., Dillingham, I., Goldacre, B., Hernan, M. A., Sterne, J. A.
10.1101/2022.03.23.22272804 — Posted: 2022-03-23
Association of COVID-19 with risks of hospitalization and mortality from other disorders post-infection: A study of the UK Biobank
XIANG, Y., ZHANG, R., QIU, J., So, H.-C.
10.1101/2022.03.23.22272811 — Posted: 2022-03-23
The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial.
Nguyen, T. P., Do, Q., Phan, L. T., Anh, D. D., Khong, H., Dinh, D. V., Hoang, L. V., Nguyen, T. V., Pham, H. N., Chu, M. V., Nguyen, T. T., Le, T. M., Trang, T. T. N., Dinh, T. T., Vo, T. V., Vu, T. T., Nguyen, Q. B. P., Phan, V. T., Nguyen, L. V., Nguyen, G. T., Tran, P. M., Nghiem, T. D., Tran, T. V., Nguyen, T. G., Tran, T. Q., Nguyen, L. T., Do, A. T., Nguyen, D. D., Ho, S. A., Nguyen, V. T., Pham, D. T., Tran, H. B., Vu, S. T., Hoang, S. X., Do, T. M., Nguyen, X. T., Le, G. Q., Tran, T., Cao, T. M., Dao, H. M., Nguyen, T. T. T., Doan, U. Y., Le, V. T. T., Tran, L. P., Nguyen, N. M., Nguyen, N. T., Pham, H. T. T., Nguyen, Q. H., Pham, Q. D., Nguyen, H. T., Nguyen, H. L. K., Trang, N. V., Nguyen, L. A. T., Nguyen, L. T., Trinh, N. T. H., Le, L. T. K., Tran, V. T. B., Chu, M. T. N., Phan, M. H., Nguyen, H. T. H., Tran, V. T., Tran, M. T. N., Nguyen, T. T. T., Ha, P. T., Huynh, H. T., Nguyen, K. D., Ung, T. T., Duong, N. H. T., Doan, C. C., Do, S. M.
10.1101/2022.03.22.22272739 — Posted: 2022-03-23
SCENTinel 1.1 rapidly screens for COVID-19 related olfactory disorders
Hunter, S. R., Hannum, M. E., Pellegrino, R., O'Leary, M. A., Rawson, N. E., Reed, D. R., Dalton, P. H., Parma, V.
10.1101/2022.03.23.22272807 — Posted: 2022-03-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).